Latest Conference Articles

News and updates about ACC.13, the 2013 Scientific Session of the American College of Cardiology.

Hepatocellular carcinoma is the fastest rising cause of cancer-related deaths in the United States. However, there are several stages along the way from healthy liver to malignant transformation that offer opportunities for detection and intervention.

Researchers have identified several mutations of genes that could predispose someone to chronic pancreatitis, while thinking has also changed when it comes to treating the pain associated with this chronic condition.

Autoimmune hepatitis often responds well to steroid therapy but identifying the disease and the best approach to management is filled with complexities.

Research has shown that patients with hereditary colorectal syndromes such as Lynch syndrome, adenomatous polyposis, and hamartomatous polyposis have a much higher likelihood of developing colorectal cancer.

With celiac disease becoming more prevalent, especially in adults, what are the most effective approaches to testing patients for this disease, and are there effective management strategies that can be used in conjunction with a gluten-free diet?

Proton pump inhibitors (PPI) are effective in many patients with gastroesophageal reflux disease (GERD), but up to half of patients do not experience symptom relief with these medications.

Expert advice from the 2013 AGA-ASGE Clinical Congress of Gastroenterology and Hepatology on managing diarrhea, constipation, abdominal pain, and other symptoms associated with irritable bowel syndrome (IBS).

News and updates about the upcoming AGA-ASGE 2013 Clinical Congress of Gastroenterology and Hepatology.

News and updates about the upcoming DDW 2013 conference.

News and updates about the upcoming ACG 2013 annual meeting.

Overweight women face a higher risk of rheumatoid arthritis than their normal-weight peers, according to a study presented at the annual scientific meeting of the American College of Rheumatology in Washington, DC.

Although many patients suffering with low back pain are initially focused on pain relief, convincing them to shift their focus to prevention and functional improvement can lead to better clinical outcomes and greater patient satisfaction.

Study results presented at The Liver Meeting 2012 show the experimental treatment leads to high rates of viral clearance in patients with hepatitis C, even in those with compensated cirrhosis.

According to study results presented at The Liver Meeting 2012, combination treatment with ribavirin and the uridine nucleotide analog sofosbuvir achieved high rates of sustained viral response in a range of patients with hepatitis C.

The development of direct acting antivirals has led to significant improvement in treatment outcomes for many patients with hepatitis C. New research has also improved management of treatment-related anemia, helped streamline standard therapy, and identified promising new approaches to interferon-free treatment.

Forty percent of patients treated with the uricase drug pegloticase saw complete resolution of one or more gouty tophi within 25 weeks.

Results presented at the American College of Rheumatology/Association of Rheumatology Professionals 2012 annual meeting show that adalimumab and methotrexate are more effective than DMARDs and prednisone in achieving remission in patients with early rheumatoid arthritis or undifferentiated arthritis patients.

Patients with Complex Regional Pain Syndrome (CRPS) may be afraid to volunteer information that helps clinicians accurately diagnose them.

Study results presented at The Liver Meeting 2012 show that administering two direct-acting antivirals results in a high rate of sustained virologic response in patients with hepatitis C who failed previous treatment with ribavirin/peginterferon.

Hospitalized patients with cirrhosis who also have hyponatremia often receive no treatment, or ineffective treatment, and are often discharged with their serum sodium too low.

Data presented at The Liver Meeting show that treatment with a combination of three direct-acting antivirals plus ribavirin achieved virus control in almost all patients with hepatitis C in a phase II study.

Study results presented at The Liver Meeting (AASLD 2012 annual meeting) show that consuming small amounts of alcohol can have net positive cardiovascular health benefits for some patients with non-alcoholic fatty liver disease.

Boceprevir and telaprevir offer improved clinical benefits to patients with hepatitis C, but a variety of racial, genetic, and other biological factors can influence treatment outcomes.

Study results presented at The Liver Meeting (2012 AASLD annual meeting) show that treatment with tenofovir disoproxil difumarate is safe and effective in this patient population.

A substudy of the PLATO trial reveals that treatment with ticagrelor reduces cardiovascular death, myocardial infarction, and stroke in some patients with non-ST-elevation acute coronary syndrome.

Results from the RELAX-AHF show serelaxin reduces cardiovascular deaths and improves symptoms in patients with heart failure.

Results from a substudy of the PLATO trial show that patients with extensive CAD and high rates of recurrent cardiovascular events, death, and bleeding may benefit from treatment with ticagrelor.

Study results presented at the American Heart Association 2012 Scientific Sessions show that visible signs of aging such as baldness and yellow fatty deposits around the eye are predictors for heart attack and heart disease risk.

Many young adults age 18-24 with high blood pressure remain undiagnosed with hypertension, even after long-term physician care.